59 days ago
Today Tern (TERN) announced that it had invested a further approximately £48,000 of cash into Talking Medicines and by cancelling existing loan notes of approximately £87,000 now has been granted £270,000 of new unsecured convertible loan notes. The RNS describes the terms of the new notes as follows:
197 days ago
Today Tern (TERN) has released detailed presentations from two of its portfolio investment companies namely Device Authority and Talking Medicines. For some reason Tern didn’t obtain a presentation for its second largest large portfolio investment namely FVRVS.
224 days ago
Today Tern (TERN) announced that it had “been issued with approximately £230,000 of new unsecured convertible loan notes by Talking Medicines Limited in return for Tern having agreed to cancel existing short-term loans aggregating to approximately £180,000 provided by Tern to Talking Medicines during 2024 and 2025.” Swings and roundabouts, smoke and mirrors
241 days ago
Today Tern (TERN) announced an extension of its Convertible Loan Notes to investee company Talking Medicines. It is a can kick but does not change the inevitable end game.
302 days ago
On 15 September 2025 Tern (TERN) announced that it had extended its loan facility had extended its repayment date from 30 September 2025 to 5 March 2026. It stated that “approximately £150,000 remains outstanding under the Loan and this amount plus accrued interest at a rate of 1.00% per calendar month”. An interest rate of 1% per month isn’t exactly cheap and just adds to the drag on Tern’s investment performance.
784 days ago
Talking about pissing good money after bad. Having raised £400,000 gross (call it £370,000 net) just eight days ago, Tern (TERN) has today spaffed £100,000 standing its corner at Talking Medicines Ltd, an eleven year old cash guzzling crock from Glasgow. Its last accounts are shocking.
